Test Code LAB2148 Dengue Virus Antibody, IgG and IgM, Serum
Additional Codes
DENGM
Useful For
Aiding in the diagnosis of dengue virus infection
Profile Information
Test ID | Reporting Name | Available Separately | Always Performed |
---|---|---|---|
DENG | Dengue Virus Ab, IgG, S | No | Yes |
DENM | Dengue Virus Ab, IgM, S | No | Yes |
DNABI | Dengue Ab Interpretation | No | Yes |
Specimen Type
SerumSpecimen Required
Collection Container/Tube:
Preferred: Serum gel
Acceptable: Red top
Submission Container/Tube: Plastic vial
Specimen Volume: 0.5 mL
Collection Instructions: Centrifuge and aliquot serum into plastic vial.
Specimen Minimum Volume
0.4 mL
Specimen Stability Information
Specimen Type | Temperature | Time | Special Container |
---|---|---|---|
Serum | Refrigerated (preferred) | 14 days | |
Frozen | 14 days |
Reject Due To
Gross hemolysis | Reject |
Gross lipemia | Reject |
Gross icterus | Reject |
Heat-inactivated specimen | Reject |
Reference Values
IgG: negative
IgM: negative
Reference values apply to all ages.
Interpretation
The presence of IgG-class antibodies to dengue virus (DV) is consistent with exposure to this virus sometime in the past. By 3 weeks following exposure, nearly all immunocompetent individuals should have developed IgG antibodies to DV.
The presence of IgM-class antibodies to DV is consistent with acute-phase infection.
IgM antibodies become detectable 3 to 7 days following infection and may remain detectable for up to 6 months or longer following disease resolution.
The absence of IgM-class antibodies to DV is consistent with lack of infection. However, specimens collected too soon following exposure may be negative for IgM antibodies to DV. If DV remains suspected, a second specimen collected approximately 10 to 12 days following exposure should be tested.
Method Description
Dengue virus IgM:
In this enzyme-linked immunosorbent assay (ELISA), samples and controls are diluted in sample dilution buffer and incubated in microtiter wells coated with antihuman IgM antibodies. This incubation is followed by incubation with dengue-derived recombinant antigens (DENRA) and normal cell antigen separately. After incubation and washing, the wells are treated with a DEN-specific monoclonal antibody labeled with horseradish peroxidase (HRP). After a second incubation and washing step, the wells are incubated with tetramethylbenzidine (TMB) substrate. Acid stop is added, and absorbance at 450 nm is read. The ratio of absorbencies of the DENRA and the control antigen wells determines whether the result is positive or negative.(Package insert: InBiOS DENV Detect IgM CAPTURE ELISA. InBios International, Inc; Revision 10/1/2019)
Dengue virus IgG:
In this ELISA assay, controls and diluted samples are incubated in microtiter wells coated with monoclonal antibody bound to DENRA. After incubation and washing, wells are treated with IgG antibody labeled with HRP. After a second incubation and washing, wells are incubated with TMB substrate. Acid stop is added, and absorbance at 450 nm is measured. The ratio of the absorbencies of the DENRA and the control wells determines whether a result is positive or negative.(Unpublished Mayo method)
Day(s) Performed
Tuesday
Report Available
Same day/1 to 7 daysSpecimen Retention Time
14 daysPerforming Laboratory
Mayo Clinic Laboratories in RochesterCPT Code Information
IgM-86790
IgG-86790
LOINC Code Information
Test ID | Test Order Name | Order LOINC Value |
---|---|---|
DENGM | Dengue Virus Ab, IgG and IgM, S | 87546-8 |
Result ID | Test Result Name | Result LOINC Value |
---|---|---|
DENG | Dengue Virus Ab, IgG, S | 29661-6 |
DENM | Dengue Virus Ab, IgM, S | 29663-2 |
DNABI | Dengue Ab Interpretation | 69048-7 |
Method Name
Enzyme-Linked Immunosorbent Assay (ELISA)
Secondary ID
83865Forms
If not ordering electronically, complete, print, and send Infectious Disease Serology Test Request (T916) with the specimen.